Mortality results from a randomized prostate-cancer screening trial by Andriole Gerald L, Crawford E David, Grubb Robert L, Buys Saundra S, Chia David, Church Timothy R, Fouad Mona N, Gelmann Edward P, Kvale Paul A, Reding Douglas J, Weissfeld Joel L, Yokochi Lance A, O'Brien Barbara, Clapp Jonathan D, Rathmell Joshua M, Riley Thomas L, Hayes Richard B, Kramer Barnett S, Izmirlian Grant, Miller Anthony B, Pinsky Paul F, Prorok Philip C, Gohagan John K, Berg Christine D, PLCO Project Team in The New England journal of medicine (2009). PubMed

Abstract

The effect of screening with prostate-specific-antigen (PSA) testing and digital rectal examination on the rate of death from prostate cancer is unknown. This is the first report from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial on prostate-cancer mortality.

[ hide abstract ]

Discussed In Paper